D:发行公告
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超过5%持股股东披露文件(修正)-Schonfeld Strategic Advisors LLC(0.18%)
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超过5%持股股东披露文件(修正)-Dellora Investments Master Fund LP(0%),Dellora Investments LP(0%)等
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超过5%持股股东披露文件(修正)-Altium Capital Management, LP EIN:(4.99%),Altium Growth Fund, LP EIN:(4.99%)等
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G/A:超过5%持股股东披露文件(修正)-Acorn Bioventures, L.P.(0%),Acorn Capital Advisors GP, LLC(0%)等
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 SCHWARTZ BRIAN
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G:超过5%持股股东披露文件-Altium Capital Management, LP EIN:(8.0%),Altium Growth Fund, LP EIN:(8.0%)等
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G:超过5%持股股东披露文件-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%)等
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 Rombotis Spiro George
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 McBarron Paul
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 Rombotis Spiro George
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 BARKER SAM L
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 Spiegel Robert J.
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 McBarron Paul
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-高管 Kirschbaum Mark
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 Walker Karin L
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 Ferguson Kenneth M.
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 HENNEY CHRISTOPHER S
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | 4:持股变动声明-董事 SCHWARTZ BRIAN
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock | SC 13G:超过5%持股股东披露文件-Schonfeld Strategic Advisors LLC(6.14%)
暂无数据
暂无数据